Overlapping cortical malformations in patients with pathogenic variants in <i>GRIN1</i> and <i>GRIN2B</i>.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 35393335.
- Also identified by DOI 10.1136/jmedgenet-2021-107971 and PMC identifier 10642159.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Malformations of cortical development (MCDs) have been reported in a subset of patients with pathogenic heterozygous variants in <i>GRIN1</i> or <i>GRIN2B</i>, genes which encode for subunits of the N-methyl-D-aspartate receptor (NMDAR). The aim of this study was to further define the phenotypic spectrum of NMDAR-related MCDs. We report the clinical, radiological and molecular features of 7 new patients and review data on 18 previously reported individuals with NMDAR-related MCDs. Neuropathological findings for two individuals with heterozygous variants in <i>GRIN1</i> are presented. We report the clinical and neuropathological features of one additional individual with homozygous pathogenic variants in <i>GRIN1</i>. Heterozygous variants in <i>GRIN1</i> and <i>GRIN2B</i> were associated with overlapping severe clinical and imaging features, including global developmental delay, epilepsy, diffuse dysgyria, dysmorphic basal ganglia and hippocampi. Neuropathological examination in two fetuses with heterozygous <i>GRIN1</i> variants suggests that proliferation as well as radial and tangential neuronal migration are impaired. In addition, we show that neuronal migration is also impaired by homozygous <i>GRIN1</i> variants in an individual with microcephaly with simplified gyral pattern. These findings expand our understanding of the clinical and imaging features of the 'NMDARopathy' spectrum and contribute to our understanding of the likely underlying pathogenic mechanisms leading to MCD in these patients.
Medical subject headings
- Epilepsy
- Microcephaly
- Receptors, N-Methyl-D-Aspartate